Sr. Finance Manager

McKesson is an impact-driven, Fortune 10 company that touches virtually every aspect of healthcare. We are known for delivering insights, products, and services that make quality care more accessible and affordable. Here, we focus on the health, happiness, and well-being of you and those we serve – we care.

What you do at McKesson matters. We foster a culture where you can grow, make an impact, and are empowered to bring new ideas. Together, we thrive as we shape the future of health for patients, our communities, and our people. If you want to be part of tomorrow’s health today, we want to hear from you.

The Sr. Manager, Retail Pharmacy Drug Margin Analytics plays a critical role within US Oncology Network (USON) Finance, serving as the subject matter expert for the financial performance of practice-based Medically Integrated Dispensing (MID) oral oncolytic programs across the network. This position is accountable for analyzing Retail Pharmacy/MID activity at the product (NDC/drug) level, translating dispensing economics into clear, actionable financial insights, and supporting forecasting, budgeting, and planning for the various USON practices.

This role partners closely with practice leadership, FP&A, GPO, Managed Care, Pharmacy Operations, and Revenue Cycle teams to develop a consistent framework for measuring retail pharmacy drug margin performance—including definitions, methodology, and executive-ready reporting. It leads modeling and scenario analysis across key margin drivers (script volume, drug mix, acquisition cost, payer reimbursement, rebates, and dispensing program economics) and establishes repeatable reporting that supports decision‑making and continuous performance improvement.

Operating at the intersection of finance, pharmacy operations, and strategy, the Sr. Manager drives continuous improvement in data quality, analytical tools, and governance for retail pharmacy margin analytics. By maintaining disciplined, transparent analytics and communicating results with executive presence, this role supports USON’s mission to deliver high‑quality, cost‑effective cancer care through strong financial stewardship of the MID portfolio.

• Serve as the finance subject matter expert for Retail Pharmacy/MID drug margin performance across USON, owning the end‑to‑end measurement approach (definitions, key metrics, methodology, and controls).
• Establish standardized, product‑level performance views and interpretation guidelines to ensure consistent understanding across practices and stakeholders.
• Lead development and refinement of financial models that explain and forecast retail pharmacy margin performance with transparency, accuracy, and decision usefulness.

• Partner directly with USON practices and key stakeholders (FP&A, Finance Ops, Pharmacy Operations, GPO, Revenue Cycle, Managed Care) to determine and validate Retail Pharmacy/MID financial performance at the product level.
• Investigate margin drivers and variances (script volume, drug mix, payer reimbursement, acquisition cost, rebates), ensuring results are well‑supported, reconciled, and communicated in business terms.
• Translate practice‑specific dispensing data into consistent network‑level reporting and comparable performance narratives.

• Deliver concise, executive‑ready reporting packages, including performance commentary, variance explanations, and forward‑looking outlooks.
• Present findings and recommendations with strong executive presence, tailoring content for senior leadership decision‑making.
• Build “so what” insight: clarify risks, opportunities, and key actions based on the financial performance signals.

• Develop scenario models (volume, timing, reimbursement sensitivity, program cost structures) to support budgeting/forecasting and strategic planning for Retail Pharmacy/MID.
• Create driver‑based views that allow leadership to understand what is changing, why, and what levers exist.
• Support annual planning cycles and in‑year…